🔎 Trials Near Me

Beranda › Kanker Prostat › California › Sacramento

Uji klinis Kanker Prostat di Sacramento, CA

19 studi untuk Kanker Prostat mencari peserta di lokasi sekitar Sacramento (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Menerima pesertaFase 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
Usia 18 ke atas · Pria · Diperbarui 2 Okt 2026 · NCT06931340

Distance-Based Exercise to Preserve Function and Prevent Disability

Menerima peserta
  • Kaiser Permanente-South Sacramento, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07059884

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Menerima pesertaFase 3
  • University of California Davis Comprehensive Cancer Center, Sacramento
Usia 18 ke atas · Pria · Diperbarui 2 Okt 2026 · NCT07200830

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Menerima pesertaFase 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06632977

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 mi jauhnya
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Menerima pesertaFase 3
  • University of California Davis (UC Davis) Comprehensive Cancer Center ( Site 0114), Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06136650

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Menerima pesertaFase 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
  • South Sacramento Cancer Center, Sacramento
Usia 18 ke atas · Pria · Diperbarui 10 Sep 2026 · NCT05946213

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Menerima pesertaFase 3
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 mi jauhnya
Usia 18 ke atas · Pria · Diperbarui 19 Agu 2026 · NCT04423211

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

Menerima pesertaFase 2
  • University of California Davis, Sacramento
Usia 18 ke atas · Pria · Diperbarui 14 Agu 2026 · NCT04812366

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Menerima pesertaFase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Usia 18 hingga 100 · Pria · Diperbarui 13 Agu 2026 · NCT05519449

Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate Biopsies

Menerima peserta
  • UC Davis Departments of Urologic Oncology, Sacramento
Usia 18 ke atas · Pria · Diperbarui 6 Agu 2026 · NCT06907446

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Menerima pesertaFase 3
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 mi jauhnya
Usia 18 ke atas · Pria · Diperbarui 14 Jul 2026 · NCT06592924

Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer

Menerima peserta
  • University of California Davis Comprehensive Cancer Center, Sacramento
Usia 18 ke atas · Pria · Diperbarui 30 Jun 2026 · NCT06178354

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

Menerima peserta
  • University of California, Davis, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jun 2026 · NCT06101290

Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

Menerima pesertaFase 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
Usia 18 ke atas · Pria · Diperbarui 14 Apr 2026 · NCT06235697

Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer

Menerima pesertaFase 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Usia 18 ke atas · Pria · Diperbarui 13 Mar 2026 · NCT06173362

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Menerima pesertaFase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT06778863

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

Menerima pesertaFase 2
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 mi jauhnya
Usia 18 ke atas · Pria · Diperbarui 29 Jan 2026 · NCT05806515

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Menerima pesertaFase 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Mercy Cancer Center - Sacramento, Sacramento
  • University of California Davis Comprehensive Cancer Center, Sacramento
  • dan 2 lainnya
Usia 18 ke atas · Pria · Diperbarui 11 Sep 2025 · NCT03678025

Uji klinis Kanker Prostat di kota lain

Studi lain di Sacramento

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.